|
|
Zeile 8: |
Zeile 8: |
| {{tp|p=34057039|t=2021. Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.|pdf=|usr=}} | | {{tp|p=34057039|t=2021. Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.|pdf=|usr=}} |
| {{ttp|p=33372854|t=2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.|pdf=|usr=}} | | {{ttp|p=33372854|t=2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.|pdf=|usr=}} |
− | {{ttp|p=33994611|t=2021. Outdoor light pollution and COVID-19: The Italian case.|pdf=|usr=} | + | {{ttp|p=33994611|t=2021. Outdoor light pollution and COVID-19: The Italian case.|pdf=|usr=}} |
| {{ttp|p=34000623|t=2021. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.|pdf=|usr=}} | | {{ttp|p=34000623|t=2021. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.|pdf=|usr=}} |
| {{ttp|p=33993053|t=2021. HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19.|pdf=|usr=}} | | {{ttp|p=33993053|t=2021. HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19.|pdf=|usr=}} |
Version vom 9. Juli 2021, 06:48 Uhr
too hot to await tagging into the topics
0709
33350904 2021. Susceptibility of Domestic Swine to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2.
|
34057039 2021. Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.
33372854 2021. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
|
33994611 2021. Outdoor light pollution and COVID-19: The Italian case.
|
34000623 2021. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.
|
33993053 2021. HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19.
|
33906069 2021. VB10, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections.
33340994 2021. Reducing transmission of SARS-CoV-2 with intranasal prophylaxis.
33867312 2021. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
|
33993402 2021. Impact of environmental factors and Sahara dust intrusions on incidence and severity of COVID-19 disease in Spain. Effect in the first and second pandemic waves.
|
33345895 2021. Did anomalous atmospheric circulation favor the spread of COVID-19 in Europe?
|
33961825 2021. Role of atmospheric particulate matter exposure in COVID-19 and other health risks in human: A review.
|
33307081 2021. On the concentration of SARS-CoV-2 in outdoor air and the interaction with pre-existing atmospheric particles.
|
33945088 2021. Particulate matter concentrations and their association with COVID-19-related mortality in Mexico during June 2020 Saharan dust event.
34036501 2021. Modeling aerosol transmission of SARS-CoV-2 from human-exhaled particles in a hospital ward.
33937731 2021. An autopsy study of the spectrum of severe COVID-19 in children: From SARS to different phenotypes of MIS-C.
|
33903855 2021. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
|
34095793 2021. Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: Data from 3,078 health care workers.
33838616 2021. Home alone? Effect of weather-induced behaviour on spread of SARS-CoV-2 in Germany.
|
34044308 2021. Probing nano-QSAR to assess the interactions between carbon nanoparticles and a SARS-CoV-2 RNA fragment.
33886935 2021. Infection of red blood cells by SARS-CoV-2: new evidence.
|
33904403 2021. Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses.
33890572 2021. SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation.
|
33843587 2021. Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node.
33369852 2021. The role of fear in modern societies: Our ancient fear response to new situations is not always helpful in a civilised society.
|
34013835 2021. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate.
|
33847245 2021. Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus. }
33975212 2021. Trade-offs between short-term mortality attributable to NO2 and O3 changes during the COVID-19 lockdown across major Spanish cities.
33940341 2021. Increased ozone pollution alongside reduced nitrogen dioxide concentrations during Vienna's first COVID-19 lockdown: Significance for air quality management.
33359457 2021. UV, ozone, and COVID-19 transmission in Ontario, Canada using generalised linear models.
34109255 2021. Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community.
|
34089033 2021. Antibody-laden nasal spray could provide COVID protection - and treatment.
34082438 2021. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
|
33827113 2021. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia.
|
34098567 2021. Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.
33915569 2021. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
33915568 2021. A molecular single-cell lung atlas of lethal COVID-19.
33854252 2021. Funders, now is the time to invest big in COVID drugs.
|
34037476 2021. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.
33893760 2021. Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
0707
33093470 2020. miR-322/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats.
33912907 2021. Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August-September, 2020.
33835416 2021. Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infection.
33975005 2021. How to interpret and use COVID-19 serology and immunology tests.
|
34089099 2021. Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children.
|
33976375 2021. Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.
34083759 2021. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus.
|
33879833 2021. Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals.
|
33995820 2021. Therapeutic application of light and electromagnetic fields to reduce hyper-inflammation triggered by COVID-19.
|
33845430 2021. The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.
|
33895457 2021. Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset.
34020131 2021. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.
|
34004573 2021. Image processing unravels the evolutionary pattern of SARS-CoV-2 against SARS and MERS through position-based pattern recognition.
33850607 2021. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification.
|
33935336 2021. Elevated Jewish Mortality from Coronavirus in England and Wales: An Epidemiological and Demographic Detective Story.
33867601 2021. South African Jewish Responses to COVID-19.
34074339 2021. Hemofiltration with the Seraph((R)) 100 Microbind((R)) Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients.
33931078 2021. COVID-19: spot urine rather than bronchoalveolar lavage fluid analysis?
33874973 2021. Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study.
34036278 2021. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings.
|
33986957 2021. The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome.
|
33940139 2021. Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?
33824832 2021. A Case of Suspected Radiation Recall Pneumonitis After a COVID-19 Infection.
|
33987042 2021. Enhanced External Counterpulsation as a Novel Treatment for Post-acute COVID-19 Sequelae.
33968515 2021. Rapid Development of Clinically Symptomatic Radiation Recall Pneumonitis Immediately Following COVID-19 Vaccination.
|
34079662 2021. Successful Spinal Cord Stimulation for Necrotizing Raynaud's Phenomenon in COVID-19 Affected Patient: The Nightmare Comes Back.
|
33835432 2021. A Mechanistic Link Between Selenium and Coronavirus Disease 2019 (COVID-19).
33969287 2021. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
34074585 2021. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
33918702 2021. Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine.
|
34001446 2021. Endoscopy during the COVID-19 pandemic: Is it time to down-grade personal protective equipment for vaccinated personnel?
|
33919780 2021. Potential Effects of Melatonin and Micronutrients on Mitochondrial Dysfunction during a Cytokine Storm Typical of Oxidative/Inflammatory Diseases.
34019703 2021. Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR.
|
33990975 2021. The natural course of COVID-19 patients without clinical intervention.
33788302 2021. Hypothesis of zinc ascorbate as best zinc ionophore for raising antiviral resistance against Covid-19.
|
33710631 2021. Assessment of the role of zinc in the prevention of COVID-19 infections and mortality: A retrospective study in the Asian and European population.
33913550 2021. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
|
33821521 2021. Maternal and perinatal outcomes and placental pathologic examination of 29 SARS-CoV-2 infected patients in the third trimester of gestation.
34053187 2021. ADAMTS13 regulation of VWF multimer distribution in severe COVID-19.
|
33880871 2021. Antibody-mediated platelet activation in COVID-19: A coincidence or a new mechanism of the dysregulated coagulation system?
|
33826233 2021. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study.
33963054 2021. ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
33910954 2021. Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity.
|
34098463 2021. Decorin as a possible strategy for the amelioration of COVID-19.
34097919 2021. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection.
34061377 2021. Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca(2+) -dependent membrane fusion.
|
33300152 2021. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19.
33935221 2021. The pathology of the brain and the eye in SARS-Co-V2 infected patients: A review.
34016876 2021. Response to Letter: The Effect of Helicobacter pylori on the Presentation and Clinical Course of COVID-19.
34016875 2021. Letter to the Editor: The role of Helicobacter Pylori Infection in COVID-19, Cause or Coincidence?
33882724 2021. Treatment of Severe Hypertriglyceridemia With Insulin Infusions in Severe COVID-19: A Case Series.
33823594 2021. Morphology and Composition of Immunodiffusion Precipitin Complexes Evaluated via Microscopy and Proteomics.
34060958 2021. "Missing in Action" in Psychiatric Nursing History: The Role of Chief Nurse Adele S. Poston and Her Band of Nurses During World War I.
33998655 2021. Acute Leukoencephalopathy with Restricted Diffusion in an Infant with Severe COVID-19 and Dengue Coinfection Progressing to West Syndrome.
34037422 2021. Coronavirus PEDV nucleocapsid protein interacts with p53 to induce cell cycle arrest in S-phase and promotes viral replication.
34081075 2021. Bamlanivimab for Prevention of COVID-19.
|
34096988 2021. Spread of Misinformation About Face Masks and COVID-19 by Automated Software on Facebook.
|
33928380 2021. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19.
|
33965070 2021. (70 pages) LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19.
33836419 2021. Are prion proteins and magnetite involved in the immune cells memory system connected to the covid-19?
|
34010015 2021. Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells.
|
33998787 2021. Sequential Therapy of Acute Kidney Injury with a DNA Nanodevice.
|
33972731 2021. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity.
33976430 2021. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.
33963333 2021. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
|
33979833 2021. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
|